AQR Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-42,932
| Closed | -$1.69M | – | 2302 |
|
|
2022
Q2 | $1.69M | Buy |
42,932
+24,384
| +131% | +$958K | ﹤0.01% | 1181 |
|
|
2022
Q1 | $684K | Buy |
18,548
+834
| +5% | +$30.8K | ﹤0.01% | 1697 |
|
|
2021
Q4 | $1.73M | Buy |
17,714
+4,569
| +35% | +$447K | ﹤0.01% | 1260 |
|
|
2021
Q3 | $1.64M | Buy |
13,145
+1,792
| +16% | +$224K | ﹤0.01% | 1267 |
|
|
2021
Q2 | $1.42M | Sell |
11,353
-2,521
| -18% | -$316K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $1.88M | Buy |
13,874
+286
| +2% | +$38.8K | ﹤0.01% | 1236 |
|
|
2020
Q4 | $1.24M | Buy |
13,588
+3,600
| +36% | +$327K | ﹤0.01% | 1405 |
|
|
2020
Q3 | $743K | Buy |
+9,988
| New | +$743K | ﹤0.01% | 1559 |
|
|
2019
Q2 | – | Sell |
-7,092
| Closed | -$504K | – | 2163 |
|
|
2019
Q1 | $504K | Buy |
+7,092
| New | +$504K | ﹤0.01% | 1801 |
|